Almas M - Search Results

1

Treatment-emergent CNS symptoms following triptan therapy are part of the attack.

Goadsby PJ, Dodick DW, Almas M, Diener HC, Tfelt-Hansen P, Lipton RB, Parsons B. Goadsby PJ, et al. Among authors: almas m. Cephalalgia. 2007 Mar;27(3):254-62. doi: 10.1111/j.1468-2982.2007.01278.x. Cephalalgia. 2007. PMID: 17381558 Review.

2

Identification of negative predictors of pain-free response to triptans: analysis of the eletriptan database.

Diener HC, Dodick DW, Goadsby PJ, Lipton RB, Almas M, Parsons B. Diener HC, et al. Among authors: almas m. Cephalalgia. 2008 Jan;28(1):35-40. doi: 10.1111/j.1468-2982.2007.01457.x. Epub 2007 Oct 16. Cephalalgia. 2008. PMID: 17941878

3

Predictors of migraine headache recurrence: a pooled analysis from the eletriptan database.

Dodick DW, Lipton RB, Goadsby PJ, Tfelt-Hansen P, Ferrari MD, Diener HC, Almas M, Albert KS, Parsons B. Dodick DW, et al. Among authors: almas m. Headache. 2008 Feb;48(2):184-93. doi: 10.1111/j.1526-4610.2007.00868.x. Headache. 2008. PMID: 18234045

4

Efficacy of eletriptan in triptan-naïve patients: results of a combined analysis.

Martin VT, Valade D, Almas M, Hettiarachchi J, Sikes C, Albert KS, Parsons B. Martin VT, et al. Among authors: almas m. Headache. 2007 Feb;47(2):181-8. doi: 10.1111/j.1526-4610.2006.00685.x. Headache. 2007. PMID: 17300357 Clinical Trial.

5

Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial.

Winner P, Linder SL, Lipton RB, Almas M, Parsons B, Pitman V. Winner P, et al. Among authors: almas m. Headache. 2007 Apr;47(4):511-8. doi: 10.1111/j.1526-4610.2007.00755.x. Headache. 2007. PMID: 17445100 Clinical Trial.

6

Quantifying the return of headache in triptan-treated migraineurs: an observational study.

Sheftell F, Almas M, Weeks R, Mathew NT, Pitman V, Lipton RB. Sheftell F, et al. Among authors: almas m. Cephalalgia. 2010 Jul;30(7):838-46. doi: 10.1177/0333102409354390. Epub 2010 Mar 17. Cephalalgia. 2010. PMID: 20647175 Clinical Trial.

7

Efficacy of eletriptan in migraine-related functional impairment: functional and work productivity outcomes.

Silberstein SD, Cady RK, Sheftell FD, Almas M, Parsons B, Albert KS. Silberstein SD, et al. Among authors: almas m. Headache. 2007 May;47(5):673-82. doi: 10.1111/j.1526-4610.2006.00633.x. Headache. 2007. PMID: 17501848 Clinical Trial.

8

Prediction of therapeutic response to pregabalin in subjects with neuropathic pain.

Almas M, Parsons B, Whalen E. Almas M, et al. Curr Med Res Opin. 2018 Dec;34(12):2041-2052. doi: 10.1080/03007995.2018.1520694. Epub 2018 Oct 18. Curr Med Res Opin. 2018. PMID: 30183410

9

Outcome for headache and pain-free nonresponders to treatment of the first attack: a pooled post-hoc analysis of four randomized trials of eletriptan 40 mg.

Landy SH, Tepper SJ, Schweizer E, Almas M, Ramos E. Landy SH, et al. Among authors: almas m. Cephalalgia. 2014 Apr;34(5):376-81. doi: 10.1177/0333102413512035. Epub 2013 Nov 21. Cephalalgia. 2014. PMID: 24265285 Free article.

10

Effect of Concomitant Pain Medications on Response to Pregabalin in Patients with Postherpetic Neuralgia or Spinal Cord Injury-Related Neuropathic Pain.

Schug SA, Parsons B, Almas M, Whalen E. Schug SA, et al. Among authors: almas m. Pain Physician. 2017 Jan-Feb;20(1):E53-E63. Pain Physician. 2017. PMID: 28072797 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters